in two prospective , randomized multicenter double-blind studies with a dosage of either 250 mg given four times a day ( study a ) or 500 mg given two times a day ( study b ) , the comparative efficacy and safety of cephalexin hydrochloride ( ly061188 ; keftab ) and cephalexin monohydrate ( keflex ) for treatment of skin and soft tissue infections were determined .
C0719220
cephalexin monohydrate
C0149778
soft tissue infections